SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-21-000650
Filing Date
2021-05-03
Accepted
2021-05-03 16:30:34
Documents
2
Period of Report
2021-04-29

Document Format Files

Seq Description Document Type Size
1 kintara_fm3apr292021.html 3  
1 kintara_fm3apr292021.xml 3 1603
2 POWER OF ATTORNEY poa.htm EX-24 5572
  Complete submission text file 0000905718-21-000650.txt   8726
Mailing Address C/O SIGNAL GENETICS, INC. 5740 FLEET STREET CARLSBAD CA 92008
Business Address
SEYMOUR TAMARA A (Reporting) CIK: 0001288232 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37823 | Film No.: 21883967

Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations